Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Redheads' Gene May Be Missing Link Between Melanoma and Parkinson's

    Targets to Therapies Initiative’s Community-Driven Approach Detailed in Paper

    The Michael J. Fox Foundation’s unique approach to finding the next wave of therapeutic ideas is detailed in the journal npj Parkinson’s Disease.
    Learn more Save for later
  • Brain scan

    Focused Ultrasound to Treat Parkinson’s Symptoms on Both Sides of the Body Approved

    The FDA approved a new bilateral focused ultrasound technique to alleviate Parkinson's symptoms. The Michael J. Fox Foundation puts it in context. Learn more.
    Learn more Save for later
  • PDIQ Room Wide Shot

    Advancing Parkinson's Research Through a Patient-centered Approach

    The Michael J. Fox Foundation puts people at the center of its research agenda, uniquely positioning it to shape the broader research landscape. Learn more.
    Learn more Save for later
  • Brain Scan on Tablet

    What We Fund: $60.6M for Tools to Detect PD and Therapies to Treat It

    In April and May 2025, The Michael J. Fox Foundation awarded $60.6M to fund 69 Parkinson’s disease research projects.
    Learn more Save for later
  • diversity clinical research.jpg

    Drug With Potential to Slow or Stop Parkinson’s Moves into Next Phase of Clinical Testing

    Prasinezumab could be among the first disease-modifying medications to become available to the public.
    Learn more Save for later
  • Promoting diversity in Parkinson's research benefits every one

    Research Roundup: Join Studies Aiming to Treat Parkinson’s Progression

    The Michael J. Fox Foundation shares recruiting studies aimed at treating Parkinson’s symptoms and slowing disease progression. Learn More.
    Learn more Save for later
  • FDA Headquarters

    New Parkinson’s Therapy Resubmitted to FDA for Consideration

    ND0612, a continuous, under-the-skin infusion of liquid levodopa/carbidopa for Parkinson’s, has been resubmitted for FDA approval. Learn more.
    Learn more Save for later
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.